[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Page S6357]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3429. Mr. MARSHALL submitted an amendment intended to be proposed 
by him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO DUAL-USE 
                   TECHNOLOGY AND BIOLOGICAL WEAPONS RESEARCH 
                   BETWEEN THE PEOPLE'S REPUBLIC OF CHINA AND THE 
                   DEPARTMENT OF HOMELAND SECURITY.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     relating to dual-use technology and biological weapons 
     research, which may include instructing the Government 
     Accountability Office to investigate dual-use technology and 
     biological weapons research between the People's Republic of 
     China and the Department of Homeland Security, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2022 through 
     2026 or the period of the total of fiscal years 2022 through 
     2031.
                                 ______